Business Description
Healios K.K. is a Japanese biomedical company focused on developing and commercializing cell-based therapies and regenerative medicines across Japan, Europe, and the United States. Its pipeline includes treatments for serious conditions such as acute respiratory distress syndrome, ischemic stroke, macular degeneration, and several forms of cancer, with products at various stages of clinical development. Founded in 2011 and based in Chiyoda, Japan, the company also conducts research into stem cell technologies as a foundation for future therapies.
